Loading cancer entity…
Loading cancer entity…
Clinical trials
404 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00958334 | Extension Study of Proellex in Women Who Have Previously Completed Study ZPU 003 | completed | Phase 2 | 65 | Repros Therapeutics Inc.INDUSTRY | 1 | Jun 18, 2019 | clinicaltrials |
| NCT00341848 | Postpartum Uterine Regression | completed | — | 374 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT00131365 | Magnetic Resonance (MR) Guided Focused Ultrasound Surgery of Uterine Fibroids | completed | N/A | 9 | InSightecINDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT02147158 | A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas | completed | Phase 3 | 432 | AllerganINDUSTRY | 2 | Jun 4, 2019 | clinicaltrials |
| NCT03072446 | Uterine Fibroid Embolization (UFE) for Symptomatic Fibroids: Comparison of Gel-Bead to Commonly Used Embolic Agents. | completed | N/A | 11 | University Hospital Southampton NHS Foundation TrustOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT02147197 | A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas | completed | Phase 3 | 157 | AllerganINDUSTRY | 1 | Apr 30, 2019 | clinicaltrials |
| NCT02655224 | A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine Fibroids | completed | Phase 3 | 65 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT02655237 | A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids | completed | Phase 3 | 281 | TakedaINDUSTRY | 1 | Mar 22, 2019 | clinicaltrials |
| NCT01142791 | Safety Study of ExAblate for the Treatment of Uterine Fibroids | completed | N/A | 121 | InSightecINDUSTRY | 1 | Mar 19, 2019 | clinicaltrials |
| NCT01285960 | ExAblate UF V2 System for the Treatment of Symptomatic Uterine Fibroids | completed | N/A | 108 | InSightecINDUSTRY | 1 | Mar 6, 2019 | clinicaltrials |
| NCT03847077 | Trial of a Patient Education Tool For Leiomyoma(PETAL) | completed | N/A | 72 | Loyola UniversityOTHER | 0 | Feb 20, 2019 | clinicaltrials |
| NCT00365989 | MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication | completed | Phase 3 | 50 | InSightecINDUSTRY | 2 | Feb 5, 2019 | clinicaltrials |
| NCT03349190 | Impact of Esmya on Fertility to Infertile Women With Fibroids Managed With Assisted Reproduction Techniques(NACRE) | completed | — | 127 | ASSOCIATION POUR LE DEVELOPPEMENT EN FECONDATION IN VITROOTHER | 2 | Jan 9, 2019 | clinicaltrials |
| NCT00295217 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation | completed | Phase 3 | 15 | InSightecINDUSTRY | 1 | Dec 20, 2018 | clinicaltrials |
| NCT01750008 | Laparoscopic Uterine Sparing Techniques Outcomes and Reinterventions(LUSTOR) | completed | N/A | 51 | Acessa Health, Inc.INDUSTRY | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02472184 | Optimal Order of Concurrent Office Hysteroscopy and Endometrial Biopsy | completed | N/A | 78 | University of South FloridaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT00166270 | MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids | completed | N/A | 70 | InSightecINDUSTRY | 1 | Jul 9, 2018 | clinicaltrials |
| NCT01992718 | What Are we Missing? Diagnosing Uterine Adenomyosis Using Ultrasound Elastography | completed | Early Phase 1 | 49 | University of MichiganOTHER | 1 | May 31, 2018 | clinicaltrials |
| NCT02059954 | Vaginal vs. Laparoscopic Hysterectomy | completed | N/A | 100 | Medical University of GrazOTHER | 1 | Apr 17, 2018 | clinicaltrials |
| NCT02954744 | High-intensity Focused Ultrasound in Treatment of Uterine Fibroid | completed | N/A | 20 | Queen Mary Hospital, Hong KongOTHER | 0 | Mar 5, 2018 | clinicaltrials |
| NCT02123069 | Vascular Function and Uterine Fibroids | completed | — | 28 | Mayo ClinicOTHER | 1 | Mar 2, 2018 | clinicaltrials |
| NCT02192606 | Does 3D Laparoscopy Improve Vaginal Cuff Suture Time?(3DRCT) | completed | N/A | 57 | Brigham and Women's HospitalOTHER | 2 | Jan 24, 2018 | clinicaltrials |
| NCT00995878 | The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. | completed | Phase 4 | 56 | Mayo ClinicOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT02131662 | Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap(ASTEROID 1) | completed | Phase 2 | 309 | BayerINDUSTRY | 13 | Dec 8, 2017 | clinicaltrials |
| NCT01715597 | Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma | completed | Phase 3 | 50 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT01793584 | Surgical Success After Laparoscopic vs Abdominal Hysterectomy | completed | N/A | 100 | University of Texas Southwestern Medical CenterOTHER | 1 | Oct 26, 2017 | clinicaltrials |
| NCT01152112 | HOME Study: Hysteroscopic Office Myomectomy Evaluation(HOME) | completed | N/A | 74 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT01369758 | MyoSure Hysteroscopic Tissue Removal System Registry Study | completed | N/A | 290 | Hologic, Inc.INDUSTRY | 1 | Sep 13, 2017 | clinicaltrials |
| NCT00891657 | Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy | completed | N/A | 15 | Integra LifeSciences CorporationINDUSTRY | 1 | Sep 7, 2017 | clinicaltrials |
| NCT02835391 | PerClot Compared to Usual Care in Gynaecology Procedures | completed | N/A | 90 | CryoLife EuropaINDUSTRY | 1 | Sep 1, 2017 | clinicaltrials |
| NCT03092999 | Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1002670 (Vilaprisan) | completed | Phase 1 | 36 | BayerINDUSTRY | 1 | Aug 18, 2017 | clinicaltrials |
| NCT02371811 | Use of v Care in Abdominal Hysterectomy | completed | N/A | 60 | Ain Shams Maternity HospitalOTHER | 1 | Aug 1, 2017 | clinicaltrials |
| NCT00332033 | Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) | completed | Phase 2 | 32 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01946178 | Clinical Study of the Mirabilis High-Intensity Focused Ultrasound System for Non-Invasive Treatment of Uterine Fibroids | completed | N/A | 73 | Mirabilis Medica, Inc.INDUSTRY | 1 | May 30, 2017 | clinicaltrials |
| NCT01936493 | Biologic Predictors of Leiomyoma Treatment Outcomes | completed | — | 38 | Elizabeth A. StewartOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT02997787 | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma | completed | — | 60 | Kayseri Education and Research HospitalOTHER_GOV | 0 | Dec 26, 2016 | clinicaltrials |
| NCT01852734 | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | completed | N/A | 52 | Odense University HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT01592903 | Somatic Stem Cells in Leiomyomas? | completed | — | 16 | IgenomixINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT01156857 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLIII) | completed | Phase 3 | 209 | PregLem SAINDUSTRY | 4 | Jan 15, 2016 | clinicaltrials |
| NCT01252069 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata (PEARLIII-extension Study) | completed | Phase 3 | 132 | PregLem SAINDUSTRY | 4 | Jan 13, 2016 | clinicaltrials |
| NCT01642472 | PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata(PEARLext2) | completed | Phase 3 | 64 | PregLem SAINDUSTRY | 4 | Jan 8, 2016 | clinicaltrials |
| NCT02620345 | Fibroids in Women of Reproductive Age and Women Pregnancy(Fibroids) | completed | Phase 4 | 22 | Trieu, Nguyen Thi, M.D.INDIV | 0 | Dec 3, 2015 | clinicaltrials |
| NCT01588899 | China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids | completed | N/A | 107 | Philips HealthcareINDUSTRY | 1 | Oct 22, 2015 | clinicaltrials |
| NCT01229826 | Magnetic Resonance Elastography (MRE) of Uterine Fibroids(MRE) | completed | — | 134 | Mayo ClinicOTHER | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00579475 | The Effect of Mifepristone on Uterine Fibroids and Breast Tissue | completed | Phase 1 | 30 | Karolinska InstitutetOTHER | 1 | May 25, 2015 | clinicaltrials |
| NCT02086370 | Prophylactic Salpingectomy for the Prevention of the Ovarian Cancer: Comparison Between Surgical Techniques(Rad_PBS) | completed | N/A | 177 | University Magna GraeciaOTHER | 1 | Apr 21, 2015 | clinicaltrials |
| NCT01123603 | Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata(LOTUS) | completed | — | 860 | The Cleveland ClinicOTHER | 1 | Jan 14, 2015 | clinicaltrials |
Data updated 23 days agoSource updated Jun 18, 2019source: clinicaltrials